2017 Q2 Form 10-Q Financial Statement

#000153702817000080 Filed on July 27, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $21.29M $15.16M
YoY Change 40.45% -28.11%
Cost Of Revenue $15.81M $7.400M
YoY Change 113.65% -38.64%
Gross Profit $5.480M $7.760M
YoY Change -29.38% -14.06%
Gross Profit Margin 25.75% 51.2%
Selling, General & Admin $3.435M $5.005M
YoY Change -31.37% 33.29%
% of Gross Profit 62.68% 64.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.330M $5.810M
YoY Change 8.95% 12.38%
% of Gross Profit 115.51% 74.87%
Operating Expenses $3.435M $5.005M
YoY Change -31.37% 33.29%
Operating Profit -$5.584M -$3.101M
YoY Change 80.07% -2038.13%
Interest Expense -$690.0K -$1.060M
YoY Change -34.91% 47.22%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.270M -$4.160M
YoY Change 50.72% 646.86%
Income Tax $34.00K $31.00K
% Of Pretax Income
Net Earnings -$6.304M -$4.191M
YoY Change 50.42% 542.79%
Net Earnings / Revenue -29.62% -27.65%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.351M -$2.494M
COMMON SHARES
Basic Shares Outstanding 37.68M shares 33.61M shares
Diluted Shares Outstanding 37.68M shares 33.61M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.500M $7.100M
YoY Change -22.54% -42.28%
Cash & Equivalents $5.465M $7.086M
Short-Term Investments
Other Short-Term Assets $10.10M $3.100M
YoY Change 225.81% -36.73%
Inventory $2.400M $2.500M
Prepaid Expenses
Receivables $12.95M $6.872M
Other Receivables $0.00 $0.00
Total Short-Term Assets $30.94M $19.52M
YoY Change 58.49% -40.6%
LONG-TERM ASSETS
Property, Plant & Equipment $271.7M $280.1M
YoY Change -3.0% -0.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $865.0K $1.339M
YoY Change -35.4% -45.59%
Total Long-Term Assets $272.6M $281.5M
YoY Change -3.15% -1.29%
TOTAL ASSETS
Total Short-Term Assets $30.94M $19.52M
Total Long-Term Assets $272.6M $281.5M
Total Assets $303.5M $301.0M
YoY Change 0.85% -5.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.83M $3.886M
YoY Change 178.56% -51.35%
Accrued Expenses $5.867M $6.461M
YoY Change -9.19% -19.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $500.0K $400.0K
YoY Change 25.0%
Total Short-Term Liabilities $17.16M $10.72M
YoY Change 60.07% -34.12%
LONG-TERM LIABILITIES
Long-Term Debt $39.50M $16.70M
YoY Change 136.53% -72.8%
Other Long-Term Liabilities $0.00 $100.0K
YoY Change -100.0% -66.67%
Total Long-Term Liabilities $39.50M $16.80M
YoY Change 135.12% -72.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.16M $10.72M
Total Long-Term Liabilities $39.50M $16.80M
Total Liabilities $57.16M $27.76M
YoY Change 105.93% -64.58%
SHAREHOLDERS EQUITY
Retained Earnings -$77.92M -$47.77M
YoY Change 63.1% 38.21%
Common Stock $326.0M $322.5M
YoY Change 1.1% 17.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.719M $1.469M
YoY Change 17.02% 51.29%
Treasury Stock Shares 218.2K shares 170.0K shares
Shareholders Equity $246.4M $273.2M
YoY Change
Total Liabilities & Shareholders Equity $303.5M $301.0M
YoY Change 0.85% -5.35%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$6.304M -$4.191M
YoY Change 50.42% 542.79%
Depreciation, Depletion And Amortization $6.330M $5.810M
YoY Change 8.95% 12.38%
Cash From Operating Activities $3.670M $8.160M
YoY Change -55.02% -34.51%
INVESTING ACTIVITIES
Capital Expenditures -$8.720M -$4.840M
YoY Change 80.17% -86.9%
Acquisitions
YoY Change
Other Investing Activities $1.050M $290.0K
YoY Change 262.07% 11.54%
Cash From Investing Activities -$7.680M -$4.560M
YoY Change 68.42% -87.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.180M -3.930M
YoY Change -155.47% -115.46%
NET CHANGE
Cash From Operating Activities 3.670M 8.160M
Cash From Investing Activities -7.680M -4.560M
Cash From Financing Activities 2.180M -3.930M
Net Change In Cash -1.830M -330.0K
YoY Change 454.55% -127.5%
FREE CASH FLOW
Cash From Operating Activities $3.670M $8.160M
Capital Expenditures -$8.720M -$4.840M
Free Cash Flow $12.39M $13.00M
YoY Change -4.69% -73.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7821000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001537028
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37807467 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Independence Contract Drilling, Inc.
CY2016Q1 icd Capital Lease Obligations Termof Contract
CapitalLeaseObligationsTermofContract
P36M
CY2016Q1 icd Market Priceof Oil
MarketPriceofOil
26.19
CY2017Q2 icd Market Priceof Oil
MarketPriceofOil
45
icd Numberof Annual Rig Appraisals
NumberofAnnualRigAppraisals
2 rig_appraisal
CY2017Q2 icd Operatingand Capital Leases Future Minimum Payments Due
OperatingandCapitalLeasesFutureMinimumPaymentsDue
1183000 USD
CY2017Q2 icd Operatingand Capital Leases Future Minimum Payments Duein Four Years
OperatingandCapitalLeasesFutureMinimumPaymentsDueinFourYears
99000 USD
CY2017Q2 icd Operatingand Capital Leases Future Minimum Payments Duein Three Years
OperatingandCapitalLeasesFutureMinimumPaymentsDueinThreeYears
332000 USD
CY2017Q2 icd Operatingand Capital Leases Future Minimum Payments Duein Two Years
OperatingandCapitalLeasesFutureMinimumPaymentsDueinTwoYears
454000 USD
CY2017Q2 icd Operatingand Capital Leases Future Minimum Payments Remainderof Fiscal Year
OperatingandCapitalLeasesFutureMinimumPaymentsRemainderofFiscalYear
298000 USD
icd Purchasesof Property Plantand Equipmentin Accounts Payable
PurchasesofPropertyPlantandEquipmentinAccountsPayable
-2577000 USD
icd Purchasesof Property Plantand Equipmentin Accounts Payable
PurchasesofPropertyPlantandEquipmentinAccountsPayable
-855000 USD
icd Sharebased Compensation Excluding Executive Retirement
SharebasedCompensationExcludingExecutiveRetirement
2360000 USD
icd Sharebased Compensation Excluding Executive Retirement
SharebasedCompensationExcludingExecutiveRetirement
2169000 USD
icd Sharebased Compensation Executive Retirement
SharebasedCompensationExecutiveRetirement
-67000 USD
icd Sharebased Compensation Executive Retirement
SharebasedCompensationExecutiveRetirement
0 USD
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5867000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10031000 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10825000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11468000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12946000 USD
CY2016Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
787000 USD
CY2017Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1094000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7821000 USD
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5867000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
323918000 USD
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
325630000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2169000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1138000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2293000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1157000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
250000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2169000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
283000 USD
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37831723 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38025637 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12591000 USD
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Assets
Assets
302107000 USD
CY2017Q2 us-gaap Assets
Assets
303533000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
27892000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
30943000 USD
CY2016Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
3915000 USD
CY2017Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
6388000 USD
CY2015Q4 us-gaap Average Production Costs Per Barrel Of Oil Equivalents Boe
AverageProductionCostsPerBarrelOfOilEquivalentsBOE
37.13
CY2014Q3 us-gaap Average Production Costs Per Barrel Of Oil Equivalents Boe
AverageProductionCostsPerBarrelOfOilEquivalentsBOE
106.06
CY2016Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
800000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
965000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
536000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5344000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7086000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7071000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5465000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1742000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1606000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37617920 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37807467 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
376000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
378000 USD
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
18256000 USD
us-gaap Costs And Expenses
CostsAndExpenses
40144000 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
26869000 USD
us-gaap Costs And Expenses
CostsAndExpenses
52698000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
80000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
396000 USD
CY2017Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
476000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1139000 USD
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1248000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
11641000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
12591000 USD
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5816000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11641000 USD
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6335000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
675000 USD
CY2016Q2 us-gaap Direct Operating Costs
DirectOperatingCosts
7398000 USD
us-gaap Direct Operating Costs
DirectOperatingCosts
19965000 USD
CY2017Q2 us-gaap Direct Operating Costs
DirectOperatingCosts
15808000 USD
us-gaap Direct Operating Costs
DirectOperatingCosts
30706000 USD
CY2017Q2 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-800000 USD
CY2016Q2 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
37000 USD
us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
-88000 USD
CY2017Q2 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
745000 USD
us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
1573000 USD
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.007
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.008
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.005
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.006
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3784000 USD
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1754000 USD
CY2016Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2017Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.059
CY2016Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2017Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
546000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4160000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4570000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6270000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12493000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6078000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-392000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
146000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-176000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
644000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-11368000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1478000 USD
CY2016Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1059000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2036000 USD
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-686000 USD
CY2016Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2336000 USD
us-gaap Interest Paid
InterestPaid
1157000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9586000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1316000 USD
us-gaap Interest Paid
InterestPaid
1426000 USD
CY2017Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2407000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
44855000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
57164000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
302107000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
303533000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18293000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17160000 USD
CY2016Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
88000 USD
CY2017Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
1000 USD
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
441000 USD
CY2017Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
468000 USD
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
26078000 USD
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
39527000 USD
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
441000 USD
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
468000 USD
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
26519000 USD
CY2017Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
39995000 USD
CY2016Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
26600000 USD
CY2017Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
39500000 USD
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
26100000 USD
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
26078000 USD
CY2017Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
39527000 USD
CY2017Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
39500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4056000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12453000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16307000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15384000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2248000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-4191000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4605000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-6304000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12573000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3101000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2534000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5584000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11177000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
168000 USD
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
148000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1027000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
865000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
183000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
24000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
217000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
8000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
455000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10521000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17367000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3102000 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3737000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
188000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
42983000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
34775000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
22611000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
747000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1060000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
273188000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
271725000 USD
CY2017Q2 us-gaap Purchase Obligation
PurchaseObligation
16000000 USD
CY2017Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
8400000 USD
CY2017Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
7600000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
81129000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
9363000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
285000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
308000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65347000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77920000 USD
CY2016Q2 us-gaap Revenues
Revenues
15155000 USD
us-gaap Revenues
Revenues
37610000 USD
CY2017Q2 us-gaap Revenues
Revenues
21285000 USD
us-gaap Revenues
Revenues
41521000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5005000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8626000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3435000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7153000 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
800700 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
135020 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
935720 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
800700.0 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.74
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.74
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.00
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y09M0D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-455000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
257252000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
246369000 USD
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1943000 USD
CY2017Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1623000 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
213803 shares
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
218170 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1695000 USD
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1719000 USD
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33608000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28812000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37679000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37613000 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33608000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28812000 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37679000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37613000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33608000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28812000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37679000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37613000 shares
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
504000 USD

Files In Submission

Name View Source Status
0001537028-17-000080-index-headers.html Edgar Link pending
0001537028-17-000080-index.html Edgar Link pending
0001537028-17-000080.txt Edgar Link pending
0001537028-17-000080-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
icd-20170630.xml Edgar Link completed
icd-20170630.xsd Edgar Link pending
icd-20170630x10q.htm Edgar Link pending
icd-20170630x10qexx311.htm Edgar Link pending
icd-20170630x10qexx312.htm Edgar Link pending
icd-20170630x10qexx321.htm Edgar Link pending
icd-20170630x10qexx322.htm Edgar Link pending
icd-20170630_cal.xml Edgar Link unprocessable
icd-20170630_def.xml Edgar Link unprocessable
icd-20170630_lab.xml Edgar Link unprocessable
icd-20170630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending